Matches in Nanopublications for { ?s ?p "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1260526.RACR5xGFJ0ZYCdwD6vbAxUU446izusp9tLS7y540VcO40130_assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260526.RACR5xGFJ0ZYCdwD6vbAxUU446izusp9tLS7y540VcO40130_provenance.
- NP1260527.RAPvQnwcHLDbIxbbpSYGhnXV151EF6A3IFV90C_iyBa7M130_assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260527.RAPvQnwcHLDbIxbbpSYGhnXV151EF6A3IFV90C_iyBa7M130_provenance.
- NP1260533.RAJzxp3fJ30hIoatifZco-aRyuWezs-aknRsdYjSJ8j50130_assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260533.RAJzxp3fJ30hIoatifZco-aRyuWezs-aknRsdYjSJ8j50130_provenance.
- NP1260531.RAyk8_9olxoJs1lp5umkzRL-dKRnmFllpi9n5W9vUbfA8130_assertion description "[B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contributing event in the pathogenesis of the aggressive form of this disease based on transgenic mouse studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260531.RAyk8_9olxoJs1lp5umkzRL-dKRnmFllpi9n5W9vUbfA8130_provenance.